Subscribe to our twitter feeds Subscribe to email digest Subscribe to email alerts

sort by: Most Recent  [   Popular Today  |   Popular This Week  ]

announced by Orpharma 10 months , category: Medical & Pharmaceutical, Science
Pheburane will be funded from the 1st December 2019 for the treatment of Urea Cycle Disorders

announced by Orpharma about 1 year , category: Medical & Pharmaceutical
MELBOURNE, Australia, April 29th, 2019 – Orpharma Pty Ltd.and Cycle Pharmaceuticals Ltd.are pleased to announce listing of NITYR™(nitisinone) tablets on the Life Saving Drugs Program (LSDP)as of the 1stof May 2019.NITYR™ was approved in June 2018 by the A